ArticleEvolutionary applications2019
Quantifying the efficacy of genetic shifting in control of mosquito-borne diseases.
Article in Evolutionary applications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Article
- Fine-scale genetic structure andFrontiers in genetics · 2022Article
- Increasing Effectiveness of Genetically Modifying Mosquito Populations: Risk Assessment of Releasing Blood-Fed Females.The American journal of tropical medicine and hygiene · 2021Article
- Quantifying the efficacy of genetic shifting in control of mosquito-borne diseases.Evolutionary applications · 2019Article
- An Evolutionary Perspective on Vector-Borne Diseases.Frontiers in genetics · 2019Review
- Genetic Variation in Insect Vectors: Death of Typology?Insects · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Many of the world's most prevalent diseases are transmitted by animal vectors such as dengue transmitted by mosquitoes. To reduce these vector-borne diseases, a promising approach is "genetic shifting": selective breeding of the vectors to be more resistant to pathogens and releasing them to the target populations to reduce their ability to transmit pathogens, that is, lower their vector competence. The efficacy of genetic shifting will depend on possible counterforces such as natural selection against low vector competence. To quantitatively evaluate the potential efficacy of genetic shifting, we developed a series of coupled genetic-demographic models that simulate the changes of vector competence during releases of individuals with low vector competence. We modeled vector competence using different genetic architectures, as a multilocus, one-locus, or two-locus trait. Using empirically determined estimates of model parameters, the model predicted a reduction of mean vector competence of at least three standard deviations after 20 releases, one release per generation, and 10% of the size of the target population released each time. Sensitivity analysis suggested that release efficacy depends mostly on the vector competence of the released population, release size, release frequency, and the survivorship of the released individuals, with duration of the release program less important. Natural processes such as density-dependent survival and immigration from external populations also strongly influence release efficacy. Among different sex-dependent release strategies, releasing blood-fed females together with males resulted in the highest release efficacy, as these females mate in captivity and reproduce when released, thus contributing a greater proportion of low-vector-competence offspring. Conclusions were generally consistent across three models assuming different genetic architectures of vector competence, suggesting that genetic shifting could generally apply to various vector systems and does not require detailed knowledge of the number of loci contributing to vector competence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.